Hot Features
プレミアム
Gyre Therapeutics Inc (GYRE)
NASDAQ
登録してリアルタイムのチャート、分析ツール、価格を入手してください。
Catalyst Biosciences Inc is a clinical-stage biopharmaceutical company. It mainly focuses on developing novel medicines to address serious medical conditions for individuals in need of treatment options. The company emphasizes product development efforts in the field of hemostasis and to develop val... Catalyst Biosciences Inc is a clinical-stage biopharmaceutical company. It mainly focuses on developing novel medicines to address serious medical conditions for individuals in need of treatment options. The company emphasizes product development efforts in the field of hemostasis and to develop valuable therapies for individuals with hemophilia. It is engaged in the clinical development of improved, next-generation subcutaneous prophylaxis using enhanced potency Factor VIIa and Factor IX variants. 詳細を表示
SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), a self-sustainable, commercial-stage biotechnology company with clinical development programs focusing on...
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.44 | 4.1825095057 | 10.52 | 11.36 | 9.01 | 71741 | 10.90540334 | CS |
| 4 | -1.09 | -9.04564315353 | 12.05 | 14.4228 | 9.01 | 125441 | 10.879685 | CS |
| 12 | -4 | -26.7379679144 | 14.96 | 19 | 9.01 | 112643 | 11.53783397 | CS |
| 26 | -4.14 | -27.417218543 | 15.1 | 19 | 8.26 | 77558 | 12.04074535 | CS |
| 52 | -8.04 | -42.3157894737 | 19 | 26.37 | 8.26 | 73612 | 13.49569932 | CS |
| 156 | 3.96 | 56.5714285714 | 7 | 30.4 | 5.88 | 81306 | 15.30939294 | CS |
| 260 | 3.96 | 56.5714285714 | 7 | 30.4 | 5.88 | 81306 | 15.30939294 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
